Company Filing History:
4 out of 310 
4 out of 116 
Years Active: 1996-1999
Title: Arvind Thakur: Innovator in Hepatitis B Research
Introduction
Arvind Thakur is a notable inventor based in Williamsville, NY (US), recognized for his contributions to medical research, particularly in the field of hepatitis B. He holds a total of four patents that showcase his innovative approaches to detecting immune responses and raising immunity against hepatitis B.
Latest Patents
Thakur's latest patents include a method for detecting immune response to hepatitis B. This invention features an anti-idiotypic antibody designated 2F10 and its permitted variants, which possess antigenic properties similar to the group-specific 'a' determinant of human hepatitis B surface antigen (HBsAg). The invention also includes a peptide chain composed of specific amino acid residues that exhibit similar properties to the HBsAg. Additionally, he has developed a method of raising an immune response using the anti-idiotypic antibody 2F10, further emphasizing the significance of his work in enhancing immune responses against hepatitis B.
Career Highlights
Throughout his career, Arvind Thakur has worked with reputable organizations such as Health Research, Inc. and University College London. His experience in these institutions has contributed to his expertise in immunology and vaccine development.
Collaborations
Thakur has collaborated with esteemed colleagues, including Yasmin M Thanavala and Ivan Maurice Roitt, who have also made significant contributions to the field of immunology.
Conclusion
Arvind Thakur's innovative work in hepatitis B research has led to valuable patents that enhance our understanding of immune responses. His contributions continue to impact the field of medical research positively.